Simplicity in every application

AAV quantification

At-line physical titer assays in AAV bioprocessing offer several benefits. They enable real-time monitoring of vector concentration during production, facilitating timely adjustments to optimize yield and quality. This approach reduces processing time and resource consumption by providing rapid feedback on vector titers. Additionally, at-line assays streamline workflow by minimizing the need for off-line sample analysis, thus enhancing process efficiency. Ultimately, these benefits contribute to faster development timelines, improved scalability, and cost-effectiveness in AAV bioprocessing.

Using RED analysis, Amperia can be placed at line to provide these analytics in a fully automated fashion. No need to send samples away to another analytical lab or perform time consuming manual processes. Simply place your samples into a well plate and Amperia will give you fast and accurate titer data.

ELISA automation​

ELISA (Enzyme-Linked Immunosorbent Assay) plays a crucial role in drug development by enabling the detection and quantification of target molecules, such as proteins or antibodies. It provides a sensitive and specific method for measuring biomarkers, evaluating drug efficacy, and monitoring drug-target interactions.  ​

Despite the adoption of automated systems for high-throughput applications, manual ELISA is still common due to its flexibility and ease of setup. However, it is a time-consuming process that requires multiple steps, which can be prone to human error and variability, resulting in reduced reproducibility, increased assay variability, and potential data inconsistencies.

Amperia is a highly versatile system that can automate the entire ELISA workflow. It is an all-in-one system, with a compact footprint suited for any laboratory. With its customizable platform, Amperia allows researchers to automate ELISA assays tailored to their specific needs, enhancing accuracy, reproducibility, and throughput. By eliminating manual handling, Amperia minimizes human errors, reduces assay variability, and ensures consistent and reliable results, thus accelerating drug development and biomedical research. In addition, Amperia’s measurement method allows for protocols not possible with traditional ELISA, such as experiments with incubation times of under a minute, repeated measurement of the same sample or tracking of dissociation. See how Amperia is used to streamline ELISA workflows or test it yourself!

Innovate with Abselion: Share ideas!

At Abselion, we value your insights and ideas. We believe that collaboration is the key to unlocking new possibilities and driving advancements in biotechnology. We are constantly striving to innovate and push the boundaries of biotechnology with our cutting-edge product, to meet the diverse needs of our customers.

We believe that the best ideas often come from those who use our products, and that's why we invite you, our valued customers, to join us in shaping the future of Biotechnology. Share your visionary ideas for new application areas of Amperia. Is there a specific challenge you're facing that could benefit from our technology?  Are there unexplored domains where we can help you to make a significant impact? We want to hear from you!

Let's pioneer the next generation of breakthroughs in biotechnology. Share your ideas with us today, and let's shape the future of Abselion together!